AGTR1 and pulmonary fibrosis: Furthermore, suppressing the ACE/Ang II/AT1R pathway using acetyl-seryl-asparyl-lysyl-proline, an anti-fibrotic peptide, reduces EMT and abnormal ECM deposition in silica-induced pulmonary interstitial fibrosis.